Expression of aquaporin 8 in colonic epithelium with diarrhoea-predominant irritable bowel syndrome

被引:20
|
作者
Wang Jun-ping [1 ]
Hou Xiao-hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastroenterol, Union Hosp, Wuhan 430022, Peoples R China
关键词
irritable bowel syndrome; diarrhoea-predominant; aquaporin; 8;
D O I
10.1097/00029330-200702020-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background We analysed and compared the aquaporin 8 (AQP8) expression in ascending and descending colon mucosa between patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) and healthy volunteers, in order to study the relationship between the clinical feature of IBS, the expression of AQP8 and the pathological mechanism of D-IBS. Methods Specimens were taken from the proximal ascending colon or distal descending colon of D-IBS patients (n=26) and healthy volunteers (n=30), and AQP8 mRNA expression of each specimen was determined by fluorescent quantitative reverse transcription polymerase chain reaction (FQ-RT-PCR). In patients with D-IBS, the relationship was analysed between AQP8 expression in both ascending and descending colons and clinical features including gender, age of onset, duration of illness, frequency of defecation, and stool characteristics. Results Although AQP8 was present in the epithelium of the ascending and descending colons in healthy persons and D-IBS patients, the AQP8 level of the D-IBS patients was significantly lower than that of the healthy persons (P < 0.01 in the ascending colon, P < 0.05 in the descending colon). AQP8 expression was not correlated with the age of patients with D-IBS (P > 0.05 both in the ascending and descending colons) or the age at the onset (P > 0.05 both in the ascending and descending colons), but closely with the duration of illness (P < 0.05 in the ascending colon, P < 0.01 in the descending colon), frequency of defecation (P < 0.01 in the ascending colon, P < 0.05 in the descending colon) and stool characteristics (P < 0.01 in the ascending colon, P > 0.05 in the descending colon). Conclusions The decreased AQP8 expression in D-IBS patients indicates that dysfunction of colonic absorption may cause reduced water absorption, loose stool and diarrhoea. The expression of AQP8 may be related to D-IBS.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [12] Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome
    Barbara, Giovanni
    Cremon, Cesare
    GUT, 2008, 57 (08) : 1035 - 1037
  • [13] Entero-endocrine cells are elevated in diarrhoea-predominant irritable bowel syndrome
    Dunlop, SP
    Wyke, H
    Jenkins, D
    Spiller, RC
    GASTROENTEROLOGY, 2001, 120 (05) : A751 - A751
  • [14] Diagnose and treat constipation- or diarrhoea-predominant irritable bowel syndrome with confidence
    Fenton, Caroline
    Kang, Connie
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (04) : 171 - 176
  • [15] Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
    Vahedi, H.
    Merat, S.
    Momtahen, S.
    Kazzazi, A. S.
    Ghaffari, N.
    Olfati, G.
    Malekzadeh, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (08) : 678 - 684
  • [16] Bile acid malabsorption and ileal histology in diarrhoea-predominant irritable bowel syndrome
    Srinivas, M.
    Basumani, P.
    Dawson, B.
    Smith, M. J.
    Lee, J. A.
    Bardhan, K. D.
    GUT, 2007, 56 : A29 - A30
  • [17] Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
    Zhu, Lingping
    Ma, Yunhui
    Ye, Shasha
    Shu, Zhiqun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [18] Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome
    Lu, CL
    Chen, CY
    Chang, FY
    Chang, SS
    Kang, LJ
    Lu, RH
    Lee, SD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (08) : 925 - 930
  • [19] Diagnose and treat constipation- or diarrhoea-predominant irritable bowel syndrome with confidence
    Caroline Fenton
    Connie Kang
    Drugs & Therapy Perspectives, 2022, 38 : 171 - 176
  • [20] Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome
    Camilleri, M.
    Acosta, A.
    Busciglio, I.
    Boldingh, A.
    Dyer, R. B.
    Zinsmeister, A. R.
    Lueke, A.
    Gray, A.
    Donato, L. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 438 - 448